vs
Side-by-side financial comparison of FENNEC PHARMACEUTICALS INC. (FENC) and SIFCO INDUSTRIES INC (SIF). Click either name above to swap in a different company.
SIFCO INDUSTRIES INC is the larger business by last-quarter revenue ($24.0M vs $13.8M, roughly 1.7× FENNEC PHARMACEUTICALS INC.). SIFCO INDUSTRIES INC runs the higher net margin — 7.5% vs -34.7%, a 42.2% gap on every dollar of revenue. On growth, FENNEC PHARMACEUTICALS INC. posted the faster year-over-year revenue change (73.8% vs 14.8%). Over the past eight quarters, SIFCO INDUSTRIES INC's revenue compounded faster (8.1% CAGR vs -26.3%).
Fennec Pharmaceuticals Inc. is a biopharmaceutical firm focused on developing and commercializing therapies to reduce treatment-related side effects in pediatric cancer patients. Its lead product targets chemotherapy-induced ototoxicity, with core North American markets serving oncology providers and vulnerable pediatric patient groups.
SIFCO Industries, Inc. (SIFCO), is a global metal component manufacturer based in Cleveland, Ohio.
FENC vs SIF — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $13.8M | $24.0M |
| Net Profit | $-4.8M | $1.8M |
| Gross Margin | — | 21.6% |
| Operating Margin | -18.5% | 10.7% |
| Net Margin | -34.7% | 7.5% |
| Revenue YoY | 73.8% | 14.8% |
| Net Profit YoY | -141.1% | 177.3% |
| EPS (diluted) | $-0.17 | $0.29 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $13.8M | $24.0M | ||
| Q3 25 | $12.5M | $22.8M | ||
| Q2 25 | $9.7M | $22.1M | ||
| Q1 25 | $8.8M | $19.0M | ||
| Q4 24 | $7.9M | $20.9M | ||
| Q3 24 | $7.0M | $21.7M | ||
| Q2 24 | $7.3M | $22.0M | ||
| Q1 24 | $25.4M | $20.5M |
| Q4 25 | $-4.8M | $1.8M | ||
| Q3 25 | $-638.0K | $-429.0K | ||
| Q2 25 | $-3.2M | $3.4M | ||
| Q1 25 | $-1.2M | $-1.4M | ||
| Q4 24 | $-2.0M | $-2.3M | ||
| Q3 24 | $-5.7M | $-443.0K | ||
| Q2 24 | $-5.6M | $72.0K | ||
| Q1 24 | $12.8M | $-1.6M |
| Q4 25 | — | 21.6% | ||
| Q3 25 | — | 9.6% | ||
| Q2 25 | — | 26.7% | ||
| Q1 25 | — | 8.3% | ||
| Q4 24 | — | 4.4% | ||
| Q3 24 | — | 10.7% | ||
| Q2 24 | — | 12.3% | ||
| Q1 24 | — | 7.3% |
| Q4 25 | -18.5% | 10.7% | ||
| Q3 25 | -1.5% | -1.7% | ||
| Q2 25 | -28.3% | 14.8% | ||
| Q1 25 | -9.2% | -4.1% | ||
| Q4 24 | -11.8% | -9.2% | ||
| Q3 24 | -74.6% | -1.5% | ||
| Q2 24 | -69.4% | 0.7% | ||
| Q1 24 | 54.2% | -6.5% |
| Q4 25 | -34.7% | 7.5% | ||
| Q3 25 | -5.1% | -1.9% | ||
| Q2 25 | -32.7% | 15.4% | ||
| Q1 25 | -13.3% | -7.3% | ||
| Q4 24 | -25.0% | -11.1% | ||
| Q3 24 | -82.2% | -2.0% | ||
| Q2 24 | -76.5% | 0.3% | ||
| Q1 24 | 50.6% | -7.8% |
| Q4 25 | $-0.17 | $0.29 | ||
| Q3 25 | $-0.02 | $-0.07 | ||
| Q2 25 | $-0.11 | $0.56 | ||
| Q1 25 | $-0.04 | $-0.23 | ||
| Q4 24 | $-0.02 | $-0.38 | ||
| Q3 24 | $-0.21 | $-0.07 | ||
| Q2 24 | $-0.20 | $0.01 | ||
| Q1 24 | $0.41 | $-0.27 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $36.8M | $1.1M |
| Total DebtLower is stronger | — | $39.0K |
| Stockholders' EquityBook value | $35.5M | $38.7M |
| Total Assets | $70.6M | $74.9M |
| Debt / EquityLower = less leverage | — | 0.00× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $36.8M | $1.1M | ||
| Q3 25 | $21.9M | $491.0K | ||
| Q2 25 | $18.7M | $2.0M | ||
| Q1 25 | $22.7M | $1.9M | ||
| Q4 24 | $26.6M | $3.1M | ||
| Q3 24 | $40.3M | $1.7M | ||
| Q2 24 | $43.1M | $3.4M | ||
| Q1 24 | $51.2M | $2.5M |
| Q4 25 | — | $39.0K | ||
| Q3 25 | $19.4M | $51.0K | ||
| Q2 25 | $19.4M | — | ||
| Q1 25 | $19.4M | — | ||
| Q4 24 | $19.3M | — | ||
| Q3 24 | $32.1M | $0 | ||
| Q2 24 | $31.8M | $3.6M | ||
| Q1 24 | $31.3M | $4.1M |
| Q4 25 | $35.5M | $38.7M | ||
| Q3 25 | $-4.5M | $36.9M | ||
| Q2 25 | $-7.5M | $35.8M | ||
| Q1 25 | $-5.9M | $32.4M | ||
| Q4 24 | $-5.9M | $33.7M | ||
| Q3 24 | $-5.2M | $30.4M | ||
| Q2 24 | $-1.4M | $29.8M | ||
| Q1 24 | $3.0M | $29.7M |
| Q4 25 | $70.6M | $74.9M | ||
| Q3 25 | $49.3M | $73.4M | ||
| Q2 25 | $44.9M | $77.3M | ||
| Q1 25 | $46.4M | $78.8M | ||
| Q4 24 | $44.9M | $81.0M | ||
| Q3 24 | $58.9M | $104.6M | ||
| Q2 24 | $63.2M | $106.3M | ||
| Q1 24 | $69.2M | $104.2M |
| Q4 25 | — | 0.00× | ||
| Q3 25 | — | 0.00× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.00× | ||
| Q2 24 | — | 0.12× | ||
| Q1 24 | 10.40× | 0.14× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-6.0M | $8.1M |
| Free Cash FlowOCF − Capex | — | $8.0M |
| FCF MarginFCF / Revenue | — | 33.3% |
| Capex IntensityCapex / Revenue | — | 0.4% |
| Cash ConversionOCF / Net Profit | — | 4.51× |
| TTM Free Cash FlowTrailing 4 quarters | — | $11.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-6.0M | $8.1M | ||
| Q3 25 | $1.5M | $726.0K | ||
| Q2 25 | $-3.7M | $371.0K | ||
| Q1 25 | $-4.3M | $2.8M | ||
| Q4 24 | $-1.5M | $-3.8M | ||
| Q3 24 | $-2.2M | $857.0K | ||
| Q2 24 | $-8.4M | $382.0K | ||
| Q1 24 | $39.0M | $-3.2M |
| Q4 25 | — | $8.0M | ||
| Q3 25 | — | $566.0K | ||
| Q2 25 | — | $310.0K | ||
| Q1 25 | — | $2.7M | ||
| Q4 24 | — | $-3.9M | ||
| Q3 24 | — | $580.0K | ||
| Q2 24 | — | $-175.0K | ||
| Q1 24 | — | $-3.9M |
| Q4 25 | — | 33.3% | ||
| Q3 25 | — | 2.5% | ||
| Q2 25 | — | 1.4% | ||
| Q1 25 | — | 14.1% | ||
| Q4 24 | — | -18.8% | ||
| Q3 24 | — | 2.7% | ||
| Q2 24 | — | -0.8% | ||
| Q1 24 | — | -18.9% |
| Q4 25 | — | 0.4% | ||
| Q3 25 | — | 0.7% | ||
| Q2 25 | — | 0.3% | ||
| Q1 25 | — | 0.8% | ||
| Q4 24 | — | 0.5% | ||
| Q3 24 | — | 1.3% | ||
| Q2 24 | — | 2.5% | ||
| Q1 24 | — | 3.3% |
| Q4 25 | — | 4.51× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.11× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 5.31× | ||
| Q1 24 | 3.04× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FENC
Segment breakdown not available.
SIF
| Fixed Wing Aircraft Revenue | $10.5M | 44% |
| Commercial Revenue | $8.7M | 36% |
| Commercial Product And Other Revenue | $2.8M | 12% |
| Commercial Space | $1.1M | 5% |
| Other | $840.0K | 4% |
